The landscape of dementia diagnosis has progressed dramatically with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-based assessments that will detect Alzheimer's pathology many years right before indicators emerge. When these technological improvements represent extraordinary progress in being familiar with neurodegenerative conditions, th... https://hippof208enw7.wikiannouncement.com/user